Mediplus Pharma, Inc. — Our Vision
The current CTO, Gotaro Shiota, took over the management of Mediplus Pharma, Inc. from his father, the previous president. Since then, we have continued our research and development (R&D) and business operations with the following three goals.
These goals are referred to as the “Mediplus Vision.” We will continue to make concerted efforts to contribute to the realization of a “happier society.”
(1) Realization of a society in which people and animals can live long and healthy lives
We will contribute to the realization of a society in which humans and pets can live long and healthy lives while avoiding reliance on nursing care and treatment as much as possible.
(2) Realization of a society in which fundamental therapies, in addition to symptomatic treatment, are available
We will contribute to the realization of a society in which, in addition to symptomatic treatment in the medical field or temporary and emergency treatments, fundamental therapies based on regenerative care (e.g., immunotherapy, a treatment that maximizes a person’s intrinsic resilience and restorative powers) are widely practiced.
(3) Realization of a society in which everyone has access to the best medical and cosmetic products
We will contribute to the realization of a society in which expensive treatments, cutting-edge medical care, and highly functional cosmetics are affordable and accessible to all, not just a select few.
Our proprietary patented ingredients, “novel glycerin compounds,” have a wonderful ability to enhance the intrinsic power of humans and animals via a biological response. We will continue our R&D to gain a better understanding of these compounds and maximize their potential to help us achieve our corporate vision.
In addition, we will continue to elucidate the mechanism of “drawing out the intrinsic power of humans and animals,” which has yet to be fully explained by current science. Simultaneously, we will develop ingredients that extract such power and advance the technology for their utilization.
Board of Directors, Corporate Auditors, and employees of Mediplus Pharma, Inc.
CTO Gotaro Shiota
Active glycerin (Ozonized Glycerin) is the result of approximately 50 years of innovative research and development (R&D) since Mediplus Pharma’s inception (formerly VMC Co., Ltd.).
Our patented ingredient, ozonated glycerin, is a 100% plant-based raw material.Glycerin is commonly used in foods, cosmetics, and pharmaceuticals. We have made glycerin highly functional without the use of any chemicals, but rather through our unique patented technology. Not only is the raw material derived from plants, but the manufacturing process is also chemical-free, making it extremely sustainable and safe for humans, animals, and the earth (the environment). On the contrary, while sustainable materials tend to be gentle, they often lack effectiveness and practicality.
Ozonated glycerin, discovered during drug discovery for skin diseases such as atopic dermatitis, is still being researched as a therapeutic agent. However, we believe that this ingredient meets the needs of the future by being completely safe for the global environment while also being highly functional.
This is solely because ozonated glycerin enhances the body’s functions. Until now, the industry’s unwavering consensus has been in favor of antioxidants and against oxidation. However, the body is balanced between oxidation and reduction; there is no shortcut that simply removes reactive oxygen species. This approach of “maintaining balance” is known as redox*, and it is a new concept in drug discovery and cosmetics.
In other words, it is important to acknowledge the body’s functions and enhance its self-healing power.
We have discovered that active glycerin promotes the expression of genes involved in the skin barrier, antiinflammatory function, and wound healing via a biological response. In other words, it is a phenomenon that activates the switch for intrinsic health and beauty.
Science is evolving rapidly; medicine is shifting from symptomatic to radical treatment, and the day is approaching when we will be able to enjoy essential health.
We will accelerate our R&D to contribute to the extension of the healthy life spans of humans and animals through our products and services that use this active glycerin as well as to contribute to society through pharmaceuticals and cosmetics.
*Redox is an abbreviation of “reduction–oxidation reaction.” Redox reaction (reduction–oxidation reaction). A chemical reaction in which electrons are exchanged between atoms, ions, or compounds in the process of producing products from reactants.